27518527|t|Primary pituitary diffuse large B-cell lymphoma with somatotroph hyperplasia and acromegaly: case report
27518527|a|Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma and comprises approximately 30% of all lymphomas. Patients typically present with a nonpainful mass in the neck, groin, or abdomen associated with constitutional symptoms. In this report, however, the authors describe a rare case of a 61- year -old woman with hyperprolactinemia, hypothyroidism, and acromegaly (elevation of insulin-like growth factor-1 [IGF-1]) with elevated growth hormone-releasing hormone (GHRH) in whom an MRI demonstrated diffuse enlargement of the pituitary gland. Despite medical treatment, the patient had persistent elevation of IGF-1. She underwent a transsphenoidal biopsy, which yielded a diagnosis of DLBCL with an activated B-cell immunophenotype with somatotroph hyperplasia. After stereo-tactic radiation therapy in combination with chemotherapy, she is currently in remission from her lymphoma and has normalized IGF-1 levels without medical therapy, 8 months after her histopathological diagnosis. This is the only reported case of its kind and displays the importance of a broad differential diagnosis, multidisciplinary evaluation, and critical intraoperative decision-making when treating atypical sellar lesions.
27518527	0	7	Primary	T080	C0205225
27518527	8	17	pituitary	T023	C0032005
27518527	18	47	diffuse large B-cell lymphoma	T191	C0079744
27518527	53	76	somatotroph hyperplasia	T190	C0342369
27518527	81	91	acromegaly	T047	C0001206
27518527	93	104	case report	T170	C0085973
27518527	105	134	Diffuse large B-cell lymphoma	T191	C0079744
27518527	136	141	DLBCL	T191	C0079744
27518527	155	161	common	T081	C0205214
27518527	162	166	type	T080	C0332307
27518527	170	190	non-Hodgkin lymphoma	T191	C0024305
27518527	230	239	lymphomas	T191	C0024299
27518527	241	249	Patients	T101	C0030705
27518527	260	267	present	T033	C0150312
27518527	275	285	nonpainful	T169	C0234226
27518527	286	290	mass	T033	C0577559
27518527	298	302	neck	T029	C0027530
27518527	304	309	groin	T029	C0018246
27518527	314	321	abdomen	T029	C0000726
27518527	322	337	associated with	T080	C0332281
27518527	338	361	constitutional symptoms	T184	C0009812
27518527	371	377	report	T170	C0684224
27518527	392	399	authors	T097	C3812881
27518527	411	415	rare	T080	C0522498
27518527	416	420	case	T169	C0868928
27518527	430	434	year	T079	C1510829
27518527	440	445	woman	T098	C0043210
27518527	451	469	hyperprolactinemia	T047	C0020514
27518527	471	485	hypothyroidism	T047	C0020676
27518527	491	501	acromegaly	T047	C0001206
27518527	503	512	elevation	T080	C0205250
27518527	516	544	insulin-like growth factor-1	T116,T123	C0021665
27518527	546	551	IGF-1	T116,T123	C0021665
27518527	559	567	elevated	T080	C0205250
27518527	568	600	growth hormone-releasing hormone	T116,T125	C0037668
27518527	602	606	GHRH	T116,T125	C0037668
27518527	619	622	MRI	T060	C0024485
27518527	623	635	demonstrated	T080	C0443289
27518527	636	678	diffuse enlargement of the pituitary gland	T184	C0877018
27518527	688	705	medical treatment	T061	C0418981
27518527	711	718	patient	T101	C0030705
27518527	723	733	persistent	T079	C0205322
27518527	734	743	elevation	T080	C0205250
27518527	747	752	IGF-1	T116,T123	C0021665
27518527	770	792	transsphenoidal biopsy	T060	C0176118
27518527	800	807	yielded	T052	C1999230
27518527	810	819	diagnosis	T033	C0011900
27518527	823	828	DLBCL	T191	C0079744
27518527	837	846	activated	T052	C1879547
27518527	847	853	B-cell	T025	C0004561
27518527	854	869	immunophenotype	T059	C0079611
27518527	875	898	somatotroph hyperplasia	T190	C0342369
27518527	906	937	stereo-tactic radiation therapy	T061	C3896609
27518527	941	952	combination	T080	C0205195
27518527	958	970	chemotherapy	T061	C3665472
27518527	979	988	currently	T079	C0521116
27518527	992	1001	remission	T191	C0687702
27518527	1011	1019	lymphoma	T191	C0024299
27518527	1028	1038	normalized	T062	C1882115
27518527	1039	1044	IGF-1	T116,T123	C0021665
27518527	1045	1051	levels	T080	C0441889
27518527	1060	1075	medical therapy	T061	C0418981
27518527	1079	1085	months	T079	C0439231
27518527	1096	1113	histopathological	T169	C0243140
27518527	1114	1123	diagnosis	T033	C0011900
27518527	1142	1150	reported	T170	C0684224
27518527	1151	1155	case	T169	C0868928
27518527	1207	1229	differential diagnosis	T060	C0011906
27518527	1231	1259	multidisciplinary evaluation	T060	C0729737
27518527	1265	1273	critical	T080	C1511545
27518527	1274	1288	intraoperative	T079	C0456904
27518527	1289	1304	decision-making	T041	C0011109
27518527	1310	1318	treating	T169	C1522326
27518527	1328	1334	sellar	T023	C0036609
27518527	1335	1342	lesions	T033	C0221198